REDWOOD CITY, Calif.,
Aug. 24, 2017 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device company
that is providing innovative evidence-based solutions for the
treatment of chronic pain, today announced that its management is
scheduled to present at the following upcoming investor
conferences:
Event: Wells Fargo 2017 Healthcare Conference
Location: Boston, MA at the
Westin Boston Waterfront Hotel
Date: Thursday, September 7,
2017
Time: 10:35 a.m. ET /
7:35 a.m. PT
Event: Morgan Stanley Global Healthcare Conference
Location: New York City, NY
at the Grand Hyatt New York Hotel
Date: Wednesday, September 13,
2017
Time: 11:05 a.m. ET /
8:05 a.m. PT
Each presentation will be accessible via a live audio webcast,
accessible in the "Investors" section of the Company's website at:
http://www.nevro.com/investors. Following each presentation,
an archived copy will be available on the Investor Events and
Presentations webpage of the Company's website.
About Nevro
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on providing innovative products that improve the quality of life
of patients suffering from debilitating chronic pain. Nevro has
developed and commercialized the Senza spinal cord stimulation
(SCS) system, an evidence-based neuromodulation platform for the
treatment of chronic pain. The Senza system is the only SCS system
that delivers Nevro's proprietary HF10 therapy. Senza, HF10, Nevro
and the Nevro logo are trademarks of Nevro.
Investor Relations Contact:
Nevro Investor
Relations
Katherine Bock
(650) 433-3247
ir@nevro.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/nevro-to-present-at-upcoming-investor-conferences-300509376.html
SOURCE Nevro Corp.